JO
THRD

John Overdeck’s Third Harmonic Bio THRD Stock Holding History

John Overdeck’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-58,829
Closed -$319K – 3929
2025
Q2 		$319K Buy
58,829
+10,800
+22% +$53.9K ﹤0.01% 2767
2025
Q1 		$167K Buy
+48,029
New +$233K ﹤0.01% 2887
2024
Q2 		– Sell
-23,848
Closed -$225K – 3331
2024
Q1 		$225K Buy
+23,848
New +$232K ﹤0.01% 2668
2022
Q4 		– Sell
-25,000
Closed -$474K – 3081
2022
Q3 		$474K Buy
+25,000
New +$451K ﹤0.01% 1802

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

John Overdeck's THRD Position: Q3 2025 in Review

John Overdeck sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 58,829 shares — an estimated $319K sold.

John Overdeck first reported a position in THRD in Q3 2022 and held it in 4 quarters. The position peaked at $474K in Q3 2022. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • John Overdeck reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • John Overdeck sold 58,829 Third Harmonic Bio shares in Q3 2025, an estimated $319K.
  • John Overdeck first reported a position in Third Harmonic Bio in Q3 2022 and held it in 4 quarters.
  • John Overdeck's Third Harmonic Bio position peaked at $474K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.